ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1174

Class 3 Semaphorins Modulate the Invasive Capacity of Rheumatoid Arthritis Fibroblast-like Synoviocytes

Samuel Garcia Perez1, Bea Malvar Fernandez1, Simon P. Newsom2, Man Wai Tang2, T.R.D.J. Radstake3, Dominique Baeten2, Paul P. Tak2,4 and Kris A. Reedquist1, 1Department of Rheumatology and Clinical Immunology and Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 3Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 4University of Cambridge and GlaxoSmithKline, Stevenage, United Kingdom

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: fibroblasts and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

The semaphorin family is a large group of proteins initially described as axon guidance molecules that play crucial roles in the development of the nervous system. However, semaphorins also play a role in other processes such as the regulation of immunity, angiogenesis, apoptosis and cell migration and invasion. Moreover, semaphorins have been related with the pathogenesis of diseases like multiple sclerosis, myocarditis, atherosclerosis and cancer. Importantly, class 3 semaphorins Sema3B and Sema3F have been defined as important tumor suppressors. However, the potential role of class 3 semaphorins in rheumatoid arthritis (RA) remains unknown.

The aim of this study is analyze the role of class 3 semaphorins in the pathology of RA.

Methods: mRNA expression of class 3 semaphorins in the synovial tissue of early, DMARD-naive arthritis patients was analyzed by low-density (q)uantitative PCR array. RA FLS were stimulated for 4h with IL-1β (1 ng/ml), TNF (10 ng/ml) or LPS (1 μg/ml). RNA was isolated, transcribed to mRNA and expression of class 3 semaphorins was analyzed by qPCR. FLS were stimulated with Sema3A, Sema3B or Sema3F (100 ng/ml) in the presence or absence of PDGF (10 ng/ml) and cell migration and invasion were determined using wound closure motility and transwell invasion assays, respectively.

Results: mRNA expression of class 3 semaphorins in the synovial tissue of early arthritis patients negatively and significantly correlated with the mRNA expression of inflammatory mediators and the disease activity parameters of these patients. Moreover, Sema3B, Sema3C, Sema3F and Sema3G mRNA expression was significantly lower in early arthritis patients who developed persistent diseases compared with patients with self-limiting disease after two year follow-up. Also, Sema3F and Sema3B expression was significantly lower in the patients that after 2 years of follow-up progressed to RA compared to those who remained as undifferentiated arthritis patients. FLS expression of Sema3A was significantly induced after IL-1, TNF or LPS stimulation, while the expression of Sema3B and Sema3F was down-regulated. Finally, functional assays showed that Sema3A significantly induced the migration and invasion of FLS. In contrast, Sema3B and Sema3F reduced spontaneous FLS migration and PDGF-induced cell invasion.

Conclusion: these data show that class 3 semaphorins are differently expressed in the synovium of early patients depending of the severity and the progression of the disease and that Sema3A, Sema3B and Sema3F play an important role in the invasiveness ability of RA FLS. Together, class 3 semaphorins and their receptors could be useful biomarkers and promising therapeutic targets for the treatment of RA.


Disclosure: S. Garcia Perez, None; B. Malvar Fernandez, None; S. P. Newsom, None; M. W. Tang, None; T. R. D. J. Radstake, None; D. Baeten, None; P. P. Tak, None; K. A. Reedquist, None.

To cite this abstract in AMA style:

Garcia Perez S, Malvar Fernandez B, Newsom SP, Tang MW, Radstake TRDJ, Baeten D, Tak PP, Reedquist KA. Class 3 Semaphorins Modulate the Invasive Capacity of Rheumatoid Arthritis Fibroblast-like Synoviocytes [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/class-3-semaphorins-modulate-the-invasive-capacity-of-rheumatoid-arthritis-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/class-3-semaphorins-modulate-the-invasive-capacity-of-rheumatoid-arthritis-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology